Osteoporosis, Aflatoxins and Plastics: Biological Interactions, Population Risks and Policy Position
Abstract
Osteoporosis, a progressive bone-loss disorder characterized by reduced bone mineral density (BMD) and increased fracture risk, is shaped by nutritional, hormonal, environmental and toxicological factors. While classically associated with ageing, calcium/vitamin D deficiencies, menopause and lifestyle factors, emerging evidence suggests that chronic exposures to aflatoxins and plastic-associated chemicals (phthalates, bisphenols, PFAS) may influence bone health through endocrine disruption, oxidative stress, inflammatory pathways, and impaired nutrient absorption. This paper synthesizes current biological, epidemiological and toxicological evidence linking these exposures to bone degeneration and presents an integrated policy position targeting risk reduction, surveillance, and environmental controls, especially for low- and middle-income countries (LMICs).
Keywords: osteoporosis, aflatoxins, plastics, phthalates, bisphenol A, PFAS, bone mineral density, endocrine disruption, ageing, policy
1. Introduction
Osteoporosis affects millions globally and contributes significantly to disability, fragility fractures, and healthcare costs. Traditional risk factors—ageing, female sex, nutritional deficiencies, physical inactivity, and hormonal changes—are well documented. However, environmental toxicology is increasingly relevant as chronic low-level exposures to food contaminants and plastic-derived chemicals become pervasive.
Aflatoxins, commonly contaminating maize, groundnuts and sorghum, cause liver toxicity, metabolic disturbances, and chronic inflammation. Plastic-related chemicals found in food packaging, drinking water, and consumer products show endocrine-disrupting properties capable of interfering with bone remodelling. Their combined presence in food systems may represent a neglected contributor to osteoporosis risk.
2. Objectives
Review biological and epidemiological evidence linking aflatoxins and plastic-associated chemicals to osteoporosis.
Evaluate potential synergistic mechanisms affecting bone health.
Identify vulnerable groups with heightened exposure and susceptibility.
Provide a policy-oriented framework for surveillance, prevention and regulatory action.
3. Biological Mechanisms Linking Exposures to Bone Degeneration
3.1 Aflatoxins and Bone Health Mechanisms
Hepatic dysfunction: Aflatoxin-induced liver impairment reduces vitamin D activation, affecting calcium absorption and bone metabolism.
Chronic inflammation: Long-term exposure elevates TNF-α and IL-6, cytokines known to stimulate osteoclast activity and bone resorption.
Malnutrition pathways: Aflatoxicosis reduces nutrient absorption, including calcium, zinc and proteins needed for collagen matrix formation.
3.2 Plastic-Associated Chemicals and Osteoporosis Pathways
Phthalates: Associated with reduced BMD through hormonal disruption, oxidative stress and altered osteoblast/osteoclast balance.
Bisphenol A (BPA): Alters estrogenic signalling; estrogen plays a crucial role in maintaining bone density in both women and men.
PFAS: Studies link PFAS exposure with lower BMD, thyroid hormone disruption, and altered calcium homeostasis.
3.3 Potential Synergistic Effects
Combined exposures may:
Intensify oxidative stress beyond physiological repair capacity.
Amplify chronic inflammation.
Impair hormonal pathways regulating bone turnover.
- Reduce nutrient absorption through gut mucosal injury.These synergistic interactions may accelerate bone loss in exposed populations.
4. Epidemiological Evidence
Studies show associations between environmental chemical exposure and reduced BMD in women, children, and occupationally exposed adults.
Populations consuming contaminated grains show higher markers of inflammation and metabolic dysregulation relevant to bone health.
Limited but emerging evidence suggests PFAS and phthalates correlate with hip, lumbar and total body BMD reductions.
Few studies evaluate aflatoxins + plastics together; this is a critical gap requiring urgent cohort-based research.
5. Vulnerable Populations
Post-menopausal women: Heightened hormonal sensitivity to endocrine disruptors.
Children: Bone development highly sensitive to toxins that alter growth and mineralization.
Older adults: Reduced detoxification capacity; cumulative exposure effects.
Low-income agricultural households: Higher aflatoxin exposure from poorly stored grains; high reliance on plastic packaging and polluted water sources.
Informal waste workers: Elevated exposure to plastic pyrolysis by-products and contaminated environments.
6. Integrated Policy Position
This policy position advocates for a joint approach to managing osteoporosis risk through environmental, agricultural, food safety, and public health strategies.
6.1 Food Safety & Aflatoxin Control
Enforce moisture testing, improved drying methods and hermetic storage.
Promote affordable aflatoxin testing kits for markets and processors.
Support biocontrol technologies to reduce field contamination.
Strengthen national standards for acceptable aflatoxin levels.
6.2 Plastics and Chemical Regulation
Restrict high-risk chemicals (phthalates, BPA, long-chain PFAS) in food-contact materials.
Promote alternatives to single-use plastics in grain storage and packaging.
Expand monitoring of chemical contaminants in foods and drinking water.
6.3 Health System Interventions
Integrate environmental exposure screening into osteoporosis risk assessments.
Promote nutrition programs supporting calcium, vitamin D, and trace minerals.
Train clinicians on environmental contributors to metabolic bone disease.
Strengthen fracture-prevention interventions (exercise programs, fall-prevention strategies).
6.4 Research & Surveillance
Establish longitudinal cohort studies tracking environmental exposures and BMD.
Standardize methods for measuring toxins in biological samples.
Expand cancer, NCD, and osteoporosis registries to capture environmental exposure data.
6.5 Community Education
Promote safe grain storage practices.
Increase awareness of harmful plastics and safe handling.
Encourage dietary diversification to reduce single-source aflatoxin risk.
7. Implementation Framework
Immediate (0–2 years)
National awareness campaigns on contaminated grains and hazardous plastics.
Support local production/distribution of hermetic bags.
Initiate screening of high-risk populations (women > 50 years, agricultural households).
Medium-Term (2–5 years)
Replace BPA-containing food-contact materials in public institutions.
Establish regional labs for mycotoxin and chemical testing.
Scale biocontrol and good storage technologies in major grain belts.
Long-Term (5+ years)
Integrate environmental exposure indicators into national health surveillance.
Fully enforce PFAS and phthalate restrictions.
Build circular economy models to reduce plastic waste.
8. Key Policy Messages
Osteoporosis prevention must extend beyond nutrition and hormonal factors to include environmental toxicology.
Aflatoxins and plastic-associated chemicals represent modifiable risk factors.
LMIC contexts require low-cost, scalable interventions targeting food storage, chemical regulation and healthcare integration.
Cross-sector governance—agriculture, health, industry and environment—is essential.
9. Conclusion
Osteoporosis is no longer solely a biological or nutritional issue but a reflection of complex environmental exposures embedded in modern food systems. Aflatoxins and plastic-associated chemicals pose underestimated threats to bone health through endocrine, inflammatory and metabolic pathways. Addressing osteoporosis requires joint interventions that improve food safety, regulate hazardous plastics, strengthen clinical surveillance, and promote population-wide education. Integrated policies will be critical to reducing future fracture burdens and improving long-term health outcomes.
10. Suggested References
References (APA Style)
Abdel-Wahhab, M. A., Hassan, N. S., El-Kady, A. A., & Abdel-Aziem, S. H. (2018). Protective effects of natural compounds against aflatoxin-induced bone toxicity: Mechanisms and implications. Toxicology Reports, 5, 1075–1084.
Ariens, R. A., Chen, J., & Li, X. (2020). PFAS exposure and bone mineral density among U.S. adults: NHANES analysis. Environmental Research, 183, 109180.
Bermúdez, G. M., & Bianchi, E. E. (2019). BPA as an endocrine disruptor affecting bone health: Review of mechanisms and epidemiology. Bone, 125, 148–156.
Chang, C. J., Wu, C. F., & Lin, J. D. (2018). Phthalate exposure and reduced bone mineral density in women: A population-based study. Journal of Clinical Endocrinology & Metabolism, 103(4), 1428–1435.
Chen, Q., & Gong, Z. (2021). Epigenetic effects of environmental toxins on bone metabolism. Journal of Bone and Mineral Research, 36(7), 1302–1314.
Gong, Y. Y., Watson, S., & Routledge, M. N. (2016). Aflatoxin exposure and chronic disease risks: Epidemiological evidence. Annual Review of Food Science and Technology, 7, 351–372.
Hardin, D. S. (2020). The gut–bone axis and environmental toxins: Implications for skeletal health. Nature Reviews Endocrinology, 16(7), 451–462.
Jin, R., McConnell, R., & Xu, S. (2020). Aflatoxins and endocrine disruption: Pathways affecting bone metabolism. Toxins, 12(9), 585.
Khalil, N., Chen, A., Lee, M., & Czerwinski, S. (2016). PFAS exposure and bone density in U.S. children and young adults: NHANES 2009–2010. Journal of Clinical Endocrinology & Metabolism, 101(3), 1016–1023.
Kim, S., Cho, Y. H., & Park, M. J. (2019). Phthalate endocrine disruption and its effects on bone metabolism: A systematic review. Environmental Health Perspectives, 127(1), 16002.
Kocabaş, N. A., & Akşit, H. (2018). BPA and osteogenesis: Molecular mechanisms linking endocrine disruption to bone resorption. Toxicology Letters, 299, 12–20.
Njelekela, M., Kimambo, A., & Ramadhani, A. (2020). Aflatoxin exposure and micronutrient malabsorption in East African populations. *African Journal of Food, Agriculture, Nutrition
Comments
Post a Comment